Syphilis and HIV: A dangerous duo

Expert Review of Anti-Infective Therapy

Volumn 3, Issue 5, 2005, Pages 825-831

  Karumudi, Usha Rani ^a   Augenbraun, Michael ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Atypical presentation; HIV; Neurosyphilis; Syphilis; Treatment

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

ANTIVIRAL ACTIVITY; CEREBROSPINAL FLUID EXAMINATION; CLINICAL FEATURE; DESENSITIZATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; EPIDEMIC; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFECTION RISK; LEUKOCYTE COUNT; NEUROLOGIC DISEASE; NEUROSYPHILIS; PATIENT MONITORING; PREVALENCE; RETREATMENT; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SINGLE DRUG DOSE; SUPERINFECTION; SYPHILIS; TREATMENT FAILURE; TREPONEMA PALLIDUM; VIRUS LOAD;

COMORBIDITY; HIV INFECTIONS; HIV-1; HUMANS; PENICILLIN G; SYPHILIS;

EID: 27544514387     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.3.5.825     Document Type: Review

References (52)

1. Golden MR, Marra CM, Holmes KK. Update on syphilis: resurgence of an old problem. J. Am. Med. Assoc. 290(11), 1510-1514 (2003).
2. Augenbraun MH. The diagnosis and management of syphilis in the HIV-infected patient. Curr. Infect. Dis. Rep. 2(1), 10-13 (2000).
3. Hall CS, Klausner JD, Bolan GA. Managing syphilis in the HIV-infected patient. Curr. Infect. Dis. Rep. 6(1), 72-81 (2004).
4. Lynn WA, Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect. Dis. 4(7), 456-466 (2004).
5. Erbelding E, Rompalo A. Changing epidemiology of syphilis and its persistent relationship with HIV. Curr. Infect. Dis. Rep. 6(2), 135-140 (2004).
6. CDC. Primary and secondary syphilis among men who have sex with men - New York City, 2001, MMWR Morb. Mortal. Wkly Rep. 51, 853-856 (2002).
7. Rompalo AM, Joesoef MR, O'Donnell JA et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex. Transm. Dis. 28(3), 158-165 (2001).
8. Rompalo AM, Lawlor J, Seaman P. Quinn TC, Zenilman JM, Hook EW. Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex. Transm. Dis. 28(8), 448-454 (2001).
9. Carbia SG, Lagodin C, Abbruzzese M et al. Lichenoid secondary syphilis. Int. J. Dermatol. 38, 53-55 (1999).
10. Jordan HF, Louw M. The moth eaten alopecia of secondary syphilis. A histopathological study of 12 patients. Am. J. Dermopathol. 17, 158-162 (1995).
11. Schofer H, Imhof M, Thoma-Greber E et al. Active syphilis in HIV infection: a multicenter retrospective survey. The German AIDS Study Group (GASG). Genitourin. Med. 72(3), 176-181 (1996).
12. Sands M, Markus A. Lues maligna, or ulceronodular syphilis, in a man infected with Human Immunodeficiency Virus: case report and review. Clin. Infect. Dis. 20(2), 387-390 (1995).
13. Hutchinson CM, Rompalo AM, Reichart CA, Hook EW. Characteristics of patients with syphilis attending Baltimore STD clinics: multiple high-risk subgroups and interactions with human immunodeficiency virus infection. Arch. Intern. Med 151(3), 511-516 (1991).
14. Rolfs RT, Joesoef MR, Hendershot EF et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N. Engl. J. Med. 337(5), 307-314 (1997).
15. Chan DJ. Syphilis and HIV co-infection: when is lumbar puncture indicated? Curr. HIV Res. 3(1), 95-98 (2005).
16. Horowitz HW, Valsamis MP. Wicher V et al. Cerebral syphilitic gumma confirmed by the polymerase chain reaction in a man with human immunodeficiency virus infection. N. Engl. J. Med. 331(22), 1488-1491 (1994).
17. Little JP, Gardner G, Acker JD, Land MA. Otosyphilis in a patient with human immunodeficiency virus: internal auditory canal gumma. Otolaryngol. Head Neck Surg. 112(3), 488-492 (1995).
18. Musher DM, Hamill RJ, Baughn RE. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann. Intern. Med. 113(11), 872-881 (1990).
19. Bordon J, Martinez-Vasquez C, Alvarez M et al. Neurosyphilis in HIV-infected patients. Eur. J. Clin. Microbial. Infect. Dis. 14, 864-869 (1995).
20. Kinghorn GR. Infectious Diseases, 2nd Edition. Mosby, London, UK, 807-816 (2004).
21. Flores JL. Syphilis, a tale of twisted treponemes. West. J. Med. 163, 552-559 (1995).
22. Marra CM. Syphilis and Human Immunodeficiency Virus: prevention and politics. Arch. Neurol. 61(10), 1505-1508 (2004).
23. Marra CM. Neurosyphilis. Curr. Neurol. Neurosci. Rep. 4(6), 435-440 (2004).
24. Funnye AS, Akhtar AJ. Syphilis and human immunodeficiency virus co-infection. J. Natl. Med. Assoc. 95, 363-382 (2003).
25. Marra CM, Maxwell CL, Smith SL et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J. Infect. Dis. 189, 369-376 (2004).
26. Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N. Engl. J. Med. 316, 1569 (1987).
27. Bordon J, Martinez-Vazquez C, de la Fuente-Aguado J et al. Response to standard syphilis treatment in patients infected with the human immunodeficiency virus. Eur. J. Clin. Microbiol. Infect. Dis. 18, 729-732 (1999).
28. Lukehart S, Hook E, Baker-Zander S et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann. Intern. Med. 109, 855-862 (1998).
29. Marra CM, Maxwell CL, Tantalo L et al. Normalization of cerebrospinal fluid abnormalities after neurosyphilis therapy: does HIV status matter? Clin. Infect. Dis. 38(7), 1001-1006 (2004).
30. Marra CM, Maxwell CL, Smith SL et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J. Infect. Dis. 189(3), 369-376 (2004).
31. Marra CM, Longstreth WT Jr, Maxwell CL, Lukehart SA. Resolution of serum and cerebrospinal fluid abnormalities after treatment of neurosyphilis. Influence of concomitant human immunodeficiency virus infection. Sex. Transm. Dis. 23(3), 184-189 (1996).
32. Hicks CB, Benson PM, Lupton GP, Tramont EC. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann. Intern. Med. 107, 492-495 (1987).
33. Augenbraun M, Rolfs R, Johnson R, Joesoef R, Pope R. Treponemal specific tests for the serodiagnosis of syphilis. Sex. Transm. Dis. 25, 549-552 (1998).
34. Haslett P, Laverty M. The prozone phenomenon in syphilis associated with HIV infection. Arch. Intern. Med. 154, 1643-1644 (1994).
35. Jurado RL, Campbell J, Martin PD. Prozone phenomenon in secondary syphilis. Has its time arrived? Arch. Intern. Med. 153, 2496-2498 (1993).
36. Malone JL, Wallace MR, Hendrick BB et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am. J. Med. 99, 55-63 (1995).
37. Janier M, Chastang C, Spindler E et al. A prospective study of the influence of HIV status on the seroreversion of serological tests for syphilis. Dermatology 198, 362-369 (1999).
38. Rompalo AM, Cannon RO, Quinn TC, Hook EW. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J. Infect. Dis. 165, 1124-1126 (1992).
39. Gwanzura L, Latif A, Bassett M, Machekano R, Katzenstein DA, Mason PR. Syphilis serology and HIV infection in Harare, Zimbabwe. Sex. Transm. Infect. 75(6), 426-430 (1999).
40. Buchacz K, Patel P, Taylor M et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 18(15), 2075-2079 (2004).
41. Rolfs RT, Joesoef MR, Hendershot EF et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N. Engl. J. Med. 337(5), 307-314 (1997).
42. Moorthy TT, Lee CT, Lim KB, Tan T. Ceftriaxone for treatment of primary syphilis in men: a preliminary study. Sex. Transm. Dis. 14(2), 116-118 (1987).
43. Stamm LV, Parrish EA. In vitro activity of azithromycin and CP-63,956 against Treponema pallidum. J. Antimicrob. Chemother. 25 (Suppl. A), 11-14 (1990).
44. Lukehart SA, Fohn MJ, Baker-Zander SA. Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J. Antimicrob. Chemother. 25 (Suppl. A), 91-99 (1990).
45. Verdon MS, Handsfield HH, Johnson RB. Pilot study of azithromycin for treatment of primary and secondary syphilis. Clin. Infect. Dis. 19(3), 486-488 (1994).
46. Mashkilleyson AL, Gomberg MA, Mashkilleyson N, Kutin SA. Treatment of syphilis with azithromycin. Int. J. STD AIDS 7(Suppl. 1) 13-15 (1996).
47. Augenbraun MH. Treatment of syphilis 2001: non-pregnant adults. Clin. Infect. Dis. 35(Suppl. 2), S187-S190 (2002).
48. Lukehart SA, Godornes C, Molini BJ et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N. Engl. J. Med. 351(2), 154-158 (2004).
49. CDC. Azithromycin treatment failures in syphilis infections in San Francisco, California, 2002-2003. MMWR Morb. Mortal. Wkly Rep. 53(9), 197-198 (2004).
50. Smith NH, Musher DM, Huang DB et al. Response of HIV-infected patients with asymptomatic syphilis to intensive intramuscular therapy with ceftriaxone or procaine penicillin. Int. J. STD AIDS 15(5), 328-332 (2004).
51. Goeman J, Kivuvu M, Nzila N et al. Similar serological response to conventional therapy for syphilis among HIV-positive and HIV-negative women. Genitourin. Med. 71(5), 275-279 (1995).
52. Marra CM, Boutin P, McArthur JC et al. A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin. Infect. Dis. 30(3), 540-544 (2000).